Xencor Inc . (NASDAQ:XNCR), a biopharmaceutical company specializing in innovative therapies for immunology and oncology, ...

Scientists at Stanford are developing a painless, topical vaccine using a common skin bacterium to trigger immunity.

The research team, studying the efficacy of a preventive antibody-based therapy, found it successfully protects monkeys from ...

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today the completion of the acquisition of Biotheus ...

Korean researchers develop Trojan horse method to produce antibodies in tumors Innovative nanoparticle platform creates tumor ...

Hopkins researchers help secure full FDA approval to treat immunocompromised COVID-19 patients—paving the way to explore ...

Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...

Acquisition to strengthen key pillar of BioNTech's oncology strategy aimed at establishing BNT327 as a pan-tumor technology platform for the treatment of advanced cancersWith the closing of the transa ...

A new antibody therapy effectively protects monkeys from severe H5N1 avian flu, offering hope for a universal flu vaccine and ...

If neurological symptoms develop, seek opinion from a neurologist/physician as early as possible, experts urge ...

The Great British Bake Off star shocked fans when she revealed she'd been diagnosed with two autoimmune diseases ...

The novel treatment consists of a single shot which is made of special proteins called antibodies that bind to the site at ...